KPHMW
KIORA PHARMACEUTICALS INC
Key Financials
Operating Income
$-12831073
↓ 384.5%
Net Income
$-10835154
↓ 401.4%
Revenue
$0
↓ 100.0%
EPS (Diluted)
$-2.64
↓ 403.4%
Shareholders' Equity
$16.1M
↓ 37.4%
Long-term Debt
$278190.00
0.0%
Cash & Equivalents
$8.7M
↑ 129.3%
Total Assets
$24.3M
↓ 33.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-3 | 5/18/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 8-K | 5/8/2026 | View on SEC |
| 10-Q | 5/8/2026 | View on SEC |
| ARS | 5/1/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
| D | 4/21/2026 | View on SEC |
| 8-K | 4/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | KPHMW |
| Company Name | KIORA PHARMACEUTICALS INC |
| CIK | 1372514 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 858-224-9600 |